Search results
Results from the WOW.Com Content Network
Opiranserin (INN Tooltip International Nonproprietary Name; developmental code name VVZ-149) is a selective and combined glycine GlyT2 transporter blocker (IC 50 Tooltip Half-maximal inhibitory concentration = 0.86 μM), purine P2X 3 receptor antagonist (IC 50 = 0.87 μM), and serotonin 5-HT 2A receptor antagonist (IC 50 Tooltip Half-maximal inhibitory concentration = 1.3 μM) which is under ...
Methylphenidate, sold under the brand names Ritalin (/ ˈ r ɪ t ə l ɪ n / RIT-ə-lin) and Concerta (/ k ə n ˈ s ɜːr t ə / kən-SUR-tə) [citation needed] among others, is a central nervous system (CNS) stimulant indicated in the pharmacotherapy of attention deficit hyperactivity disorder (ADHD) and narcolepsy.
The bureau provides administrative leadership and policy planning for the Office of the Chief of Naval Operations (OPNAV) and the U.S. Navy at large. BUPERS is led by the Chief of Naval Personnel (CHNAVPERS), who serves in an additional duty capacity as the Deputy Chief of Naval Operations for Personnel, Manpower, and Training (DCNO N1).
MXL is a 24-hour release formula designed to be taken once daily. It is available in doses between 30 mg and 200 mg in 30 mg intervals (equating to between 1.25 mg/hour and 8.33 mg/hour). MST Continus is a 12-hour release formula, therefore it is given 2 times per day.
Sacubitril/valsartan, sold under the brand name Entresto among others, is a fixed-dose combination medication for use in heart failure.It consists of the neprilysin inhibitor sacubitril and the angiotensin receptor blocker valsartan.
Belzutifan, sold under the brand name Welireg, is an anti-cancer medication used for the treatment of von Hippel–Lindau disease-associated renal cell carcinoma. [9] [11] [12] [13] It is taken by mouth. [9]
Mianserin, sold under the brand name Tolvon among others, is an atypical antidepressant that is used primarily in the treatment of depression in Europe and elsewhere in the world. [6]
After single oral administration of 100 mg the maximum plasma concentration is reached after 3 hours and amounts to 33.2 ng/mL. [3] Therapeutic concentrations of opipramol range from 140 to 550 nmol/L. [ 26 ] The plasma protein binding amounts to approximately 91% and the volume of distribution is approximately 10 L/kg. [ 3 ]